Craig Herron
Managing Director @ iSelect Fund
St Louis, United States
Craig Herron is a seed investor at iSelect Fund in St Louis focused on Biotechnology and Software. Craig Herron is the managing director at iSelect Fund.
- Total investments:
- 40
- Last investment:
- Lead investor:
- 18%
Last updated:
For AI agents: llms.txt
Industries Craig Herron invests in
Stages Craig Herron invests in
Countries Craig Herron invests in
Investment Focus
Industry
- Biotechnology 7 (18%)
- Software 6 (15%)
- Health Care 6 (15%)
- Agriculture 5 (13%)
- Therapeutics 4 (10%)
Stage
- Seed 14 (35%)
- Funding Round 7 (18%)
- Angel 3 (8%)
- Series A 2 (5%)
- Series C 2 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Geltor
|
Biodesigned proteins for beauty, wellness and beyond. | Venture - Series Unknown / Aug 07, 2025 | |
EarthOptics
|
GroundTruth Ag is a soil cloud creator specializing in sustainable agricultural management. GroundTruth offers insights into soil management and health as well as near-real-time actionable data layers that cover the physical, chemical, and biological characteristics of the soil. This technology allows farmers to obtain accurate soil informationwhile also offering carbon creditors low-cost, hyper-accurate verification. | $24M / Venture - Series Unknown / Nov 19, 2024 | |
Holobiome
|
Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems. The company's platform delivers microbiome-based therapeutics to patients and the marketplace by treating depression, anxiety, and other mental health problems including our metabolism and the immune response,enabling patients to recover quickly from their diseases easily without any pain and suffering.Holobiome was established in 2015 and is based in Cambridge, Massachusetts. | $9M / Seed / Oct 09, 2024 | |
Flywheel.io
|
Flywheel is a data management and analysis platform built specifically for scientists and the researcher's workflow. They empower research momentum by focusing on data and medical image capture, content management, scientific computation, and collaboration. With reproducible research in mind, they combine open-source methods from topuniversities, a modern web user interface, and an extensible compute engine based on containerization technology. The result is a software platform to accelerate discovery and help researchers do science, not IT.Flywheel accelerates new scientific discoveries in life-science, biotech, and academic imaging research through cloud-scale collaboration. As a result, imaging researchers are able to avoid innovation bottlenecks, and accelerate discovery by doing more science, and less IT. | $54M / Series D / Jun 03, 2023 | |
Harpe Bio
|
Harpe Bioherbicide Solutions is a Raleigh-based company that provides sustainable weed-management solutions for organic and industrial agriculture. The company was founded in 2020 by Chad Brommer and is headquartered in Raleigh, North Carolina, United States. | $10.5M / Convertible Note / Apr 18, 2023 | |
ImmunoPhotonics
|
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a strategic partnership with Veterinary Cancer Therapeutics, LLC. The company was founded in 2008 and is based in Columbia, Missouri. | $21.4M / Series B / Apr 06, 2022 | |
|
Harpe Bio
|
Harpe Bioherbicide Solutions is a Raleigh-based company that provides sustainable weed-management solutions for organic and industrial agriculture. The company was founded in 2020 by Chad Brommer and is headquartered in Raleigh, North Carolina, United States. | $3M / Series A / Feb 08, 2022 | |
|
Harpe Bio
|
Harpe Bioherbicide Solutions is a Raleigh-based company that provides sustainable weed-management solutions for organic and industrial agriculture. The company was founded in 2020 by Chad Brommer and is headquartered in Raleigh, North Carolina, United States. | $3.2M / Convertible Note / Feb 08, 2022 | |
|
Flywheel.io
|
Flywheel is a data management and analysis platform built specifically for scientists and the researcher's workflow. They empower research momentum by focusing on data and medical image capture, content management, scientific computation, and collaboration. With reproducible research in mind, they combine open-source methods from topuniversities, a modern web user interface, and an extensible compute engine based on containerization technology. The result is a software platform to accelerate discovery and help researchers do science, not IT.Flywheel accelerates new scientific discoveries in life-science, biotech, and academic imaging research through cloud-scale collaboration. As a result, imaging researchers are able to avoid innovation bottlenecks, and accelerate discovery by doing more science, and less IT. | $27M / Series C / Sep 15, 2021 | |
Benson Hill
|
Benson Hill is a crop improvement company that unlocks the natural diversity of plants and empowers innovators with a revolutionary crop design platform to develop healthier and more sustainable food and ingredients.Benson Hill empowers innovators to develop more healthy, flavorful, and sustainable food by unlocking the natural genetic diversityof plants. Benson Hill’s CropOS™ platform combines machine learning and big data with breeding techniques and plant biology to drastically accelerate and simplify the product development process. | $150M / Series D / Oct 29, 2020 | |
| See all 40 investments → | |||
Co-Investors
About iSelect Fund
From spiraling healthcare costs, to the rise of chronic diseases, to feeding a growing global population, the world is facing a complex web of interrelated challenges. iSelect was created to help solve these problems, connecting investors with the innovative companies that are fixing the food and health systems while opening up access to investmentopportunities that are making a real impact on the future of our world.
iSelect Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ken Harrington
Selection Committee
|
|||
Bobby Sandage
Member of Selection Committee
|
|||
Carter Williams
CEO and Managing Director
|
|||
|
Craig Herron
Managing Director
|
|||
Dan Schaub
COO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Craig Herron invest in?
Craig Herron invests primarily in Biotechnology, Software and Health Care startups, most often at Seed and Funding Round stage. Most of the 40 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Craig Herron last invest?
The most recent investment recorded for Craig Herron closed in Aug 2025. Shizune tracks 40 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
